Increased 17β-hydroxysteroid dehydrogenase type 1 levels in primary cervical cancer

被引:7
|
作者
Tomaszewska, Agata [1 ,2 ]
Roszak, Andrzej [3 ,4 ]
Pawlik, Piotr [5 ]
Sajdak, Stefan [5 ]
Jagodzinski, Pawel Piotr [1 ]
机构
[1] Poznan Univ Med Sci, Dept Biochem & Mol Biol, PL-60781 Poznan, Poland
[2] Poznan Univ Med Sci, Ctr Orthodont Miniimplants, Chair & Clin Maxillofacial Orthoped & Orthodont, PL-60781 Poznan, Poland
[3] Poznan Univ Med Sci, Dept Electroradiol, PL-60781 Poznan, Poland
[4] Greater Poland Canc Ctr, Dept Radiotherapy & Gynecol Oncol, Poznan, Poland
[5] Poznan Univ Med Sci, Div Gynecol Surg, PL-60781 Poznan, Poland
关键词
HSD17B1; Cervical cancer; 17; beta-Estradiol; HUMAN-PAPILLOMAVIRUS TYPE-16; CELL-LINES; SQUAMOUS CARCINOGENESIS; ESTROGEN; EXPRESSION; ESTRADIOL; RISK; E6; 17-BETA-ESTRADIOL; DEHYDROGENASES;
D O I
10.1016/j.biopha.2015.04.018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Infections with oncogenic human papillomavirus (HPV) strains are recognized as the major risk factor for developing malignant lesions in the uterine cervix. However, several findings have demonstrated cooperation between HPV infection and 17 beta-estradiol (E2) in cervical carcinogenesis. The 17 beta-hydroxysteroid dehydrogenase type 1 (HSD17B1) is the enzyme involved in the transformation of estrone (E1) into E2. In this study, we identified the HSD17B1 transcript and protein in HeLa, SiHa, Ca Ski and C-33A cervical cancer cells. These cells were able to convert E1 to E2 in a time-dependent manner. Moreover, we identified the HSD17B1 transcript and protein in primary cancerous tissues (n = 28) and in histologically unchanged tissues (n = 25). We did not observe significant differences (P = 0.33) between the HSD17B1 transcript levels in cancerous tissues and histologically unchanged tissues. However, we found an overrepresentation of the HSD17B1 protein in cancerous tissues compared with histologically unchanged tissues (P < 0.001). This overrepresentation of the HSD17B1 protein in primary cervical cancerous tissues may be responsible for the local conversion of E1 to E2. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 50 条
  • [41] Flavonoids and cinnamic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1
    Brozic, Petra
    Kocbek, Petra
    Sova, Matej
    Kristl, Julijana
    Martens, Stefan
    Adamski, Jerzy
    Gobec, Stanislav
    Rizner, Tea Lanisnik
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) : 229 - 234
  • [42] A 6β-(thiaheptanamide) derivative of estradiol as inhibitor of 17β-hydroxysteroid dehydrogenase type 1
    Poirier, D
    Dionne, P
    Anger, S
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 64 (1-2): : 83 - 90
  • [43] Transcriptional regulation of 17β-hydroxysteroid dehydrogenase type 12 by SREBP-1
    Nagasaki, Shuji
    Miki, Yasuhiro
    Akahira, Jun-ichi
    Suzuki, Takashi
    Sasano, Hironobu
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 307 (1-2) : 163 - 168
  • [44] 17β-hydroxysteroid dehydrogenase type Gene 1937 A &gt; G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population
    Lutkowska, Anna
    Roszak, Andrzej
    Jagodzinski, Pawel P.
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (02) : 317 - 322
  • [45] The expression of 11β-hydroxysteroid dehydrogenase type 1 is increased in experimental periodontitis in rats
    Takaya Nakata
    Makoto Umeda
    Hiroaki Masuzaki
    Hirofumi Sawai
    BMC Oral Health, 16
  • [46] The expression of 11β-hydroxysteroid dehydrogenase type 1 is increased in experimental periodontitis in rats
    Nakata, Takaya
    Umeda, Makoto
    Masuzaki, Hiroaki
    Sawai, Hirofumi
    BMC ORAL HEALTH, 2016, 16
  • [47] 11β-Hydroxysteroid dehydrogenase-type 2 evolved from an ancestral 17β-Hydroxysteroid dehydrogenase-type 2
    Baker, Michael E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 399 (02) : 215 - 220
  • [48] Intratumoral androgen levels in breast carcinoma with aromatase inhibitor exemestane: 17β-hydroxysteroid dehydrogenase type 2 as a marker for increased androgen actions
    Takagi, Kiyoshi
    Nagasaki, Shuji
    Onodera, Yoshiaki
    Miki, Yasuhiro
    Akahira, Jun-ichi
    Ono, Katsuhiko
    Hirakawa, Hisashi
    Sasano, Hironobu
    Suzuki, Takashi
    ENDOCRINE JOURNAL, 2010, 57 : S578 - S579
  • [49] The regulation and inhibition of 17β-hydroxysteroid dehydrogenase in breast cancer
    Purohit, A
    Tutill, HJ
    Day, JM
    Chander, SK
    Lawrence, HR
    Allan, GM
    Fischer, DS
    Vicker, N
    Newman, SP
    Potter, BVL
    Reed, MJ
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2006, 248 (1-2) : 199 - 203
  • [50] 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer
    Hashimoto, Chiaki
    Miki, Yasuhiro
    Tanaka, Sota
    Takagi, Kiyoshi
    Fue, Misaki
    Doe, Zhulanqiqige
    Li, Bin
    Yaegashi, Nobuo
    Suzuki, Takashi
    Ito, Kiyoshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)